Scientists search for clues to make cancer immunotherapy work for more people
NCT ID NCT07211139
Summary
This study aims to learn why some patients with advanced head and neck cancer respond well to immunotherapy combined with chemotherapy, while many others do not. Researchers will collect tumor tissue and blood samples from about 30 patients before and after their standard treatment to look for patterns in the immune system. The goal is to find biological markers that can help predict treatment success and guide more personalized care in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung Medical Center
RECRUITINGSeoul, Seoul, 06351, South Korea
Conditions
Explore the condition pages connected to this study.